About this trial
This is a prospective pragmatic study to assess the impact of a HPV vaccination talk in secondary school on actual vaccine dispensing in test communes compared with control communes. The talk consist on a briefing on the importance of vaccination.
This is a controlled study, since two communes will benefit from the HPV vaccination talk, while the other two will serve as controls without set up of the HPV vaccination talk. The set up of this presentation will be open-label.
Eligibility criteria
Qualifiers
3rd grade students enrolled in public secondary schools in Suresnes and Rueil-Malmaison.
Disqualifiers
Students absent on the day of the talk.
Students unwilling/unable to complete questionnaire.
Trial design
Treatments tested in this trial
- A short talk about the importance of HPV vaccination
Treatment groups
Locations
Sponsors and collaborators
Hopital Foch
Lead sponsor
Agence Regionale de Sante d'Ile de France
Collaborator
Ospharm coopérative
Collaborator
French Interregional Group of Clinical Research and Innovation
Collaborator
Communauté professionnelle territoriale de santé
Collaborator